Agenus aims to redefine cancer treatment with BOT/BAL, showing promising results in resistant cancers. Facing financial challenges, the company focuses on cost reduction, asset monetization, and strategic partnerships to advance its therapies.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing